Navigation Links
Pharmaceutical Partnership Deal Terminations
Date:9/7/2011

008-2011 89

Table 53: Top Partnership Deal Terminations, Clinical Trial Details, A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise, 2008-2010 90

Table 54: Top Partnership Deal Terminations, Clinical Trial Details, A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone, 2008-2010 90

Table 55: Top Partnership Deal Terminations, Clinical Trial Details, A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, 2008-2011 91

Table 56: Top Partnership Deal Terminations, Clinical Trial Details, A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea, 2008-2011 91

Table 57: Top Partnership Deal Terminations, Clinical Trial Details, A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes, 2008 92

Table 58: Top Partnership Deal Terminations, Clinical Trial Details, A Study of Taspoglutide in Type 2 Diabetic Patients, 2008-2009 92

Table 59: Top Partnership Deal Terminations, Clinical Trial Details, A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy 93

Table 60: Top Partnership Deal Terminations, Clinical Trial Details, A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes, 2009-2011 93

Table 61: Top Partnership Deal Terminations, Clinical Trial Details, A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination T
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
2. Webcast Alert: Isis Pharmaceuticals Hosts Dr. John Kastelein to Review Mipomersen Long-term Data Recently Presented at ESC Congress 2011
3. Omthera Pharmaceuticals, Inc. to Present at the Rodman and Renshaw 13th Annual Healthcare Conference
4. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
5. Access Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference on Monday, September 12th in New York City
6. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12
7. Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
8. Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
9. Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity
10. Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
11. Pacira Pharmaceuticals, Inc. Expands EXPAREL™ Commercial Team Infrastructure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... CLARA, Calif. , May 21, 2013 ... game-changing embedded-ultrasound platform, today announced the introduction ... that allows complete network-based communications with all ... its latest embedded-ultrasound technology, including this new ... Sao Paulo, Brazil from ...
(Date:5/21/2013)...  Vasomedical, Inc. (OTC BB: VASO) (the "Company"), a diversified ... of medical devices and in the domestic sale of diagnostic ... , President and CEO of Vasomedical, Inc. will present ... May 30, 2013 in New York City ... Company,s presentation is scheduled to begin at 9:30 a.m. EDT. ...
(Date:5/21/2013)... Calif. , May 21, 2013   ... announced today the publication of study results involving ... CyberKnife® Robotic Radiosurgery System, the most widely used ... The study followed 304 patients for a median ... post-treatment and found that 97 percent of patients ...
Breaking Medicine Technology:Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3
... THE WOODLANDS, Texas, Dec. 6, 2011 The US Oncology ... M.D., New York Oncology Hematology , and J. Russell ... discussion with oncologists on value-based reimbursement and its impact on the ... Dec. 13 at 1:00 p.m. ET/ 12 p.m. CT/ 11 a.m. ...
... and AMSTERDAM, Dec. 6, 2011 Agendia, an ... of formalin fixed, paraffin embedded tissue technology applied ... Delivering Agendia,s tests in a paraffin embedded tissue ... the superior science, development and validation found in ...
Cached Medicine Technology:The US Oncology Network to Present Webinar on Value-Based Reimbursement 2Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue 2
(Date:5/21/2013)... Antonio, TX (PRWEB) May 21, 2013 ... from the Texas Department of Aging and Disability Services. ... visits and employee interviews, ContinuCare Home Health was ... , The review is part of the Department of ... array of aging and disability services, supports and ...
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 ... Annual EB-5 Investment Summit: Dealmakers Conference in Long ... Conference will focus on exploring alternative finance through ... the latest market, legal and economic information, and ... and legal professionals within the EB-5 industry. ...
(Date:5/21/2013)... According to a May 13, 2013 New ... Botox,” Botox injections have become the most popular ... (Go to goo.gl/8iYbD). Although it is mostly associated with women, ... injection makes facial wrinkles less visible by paralyzing facial muscles. ... three months. This means that people who are conscious about ...
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to ... in the Creative Corridor region, is releasing results for ... conference on Thursday, May 23rd at 10:30 a.m. ... , The survey is a critical component ... that attract, nurture and retain people of diverse backgrounds, ...
(Date:5/21/2013)... A paper recently published in the New England ... scientists at the University of Colorado School of Medicine ... fibrosis can be used to identify individuals at risk ... a fairly common variant of the gene for mucin-5B, ... produced by the bronchial tubes. While this variant of ...
Breaking Medicine News(10 mins):Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2
... experts say , TUESDAY, Dec. 29 (HealthDay News) -- Winter,s ... but they pose extra hazards for elderly people, experts say. ... adults over age 65 in the United States. Some 1.8 ... departments for falls in 2005, and 15,800 died from their ...
... , ... System and Robert Gerson, MD, Board Certified Plastic Surgeon, will be offering free cosmetic ... ... Health System and Robert Gerson, MD, Board Certified Plastic Surgeon, will be offering free ...
... YORK, Dec. 29 Nutritionist Judy Pentra, of Patients Medical , ... can be a vulnerable time for people trying to lose weight and ... holidays and many resolve to lose the weight in January, however, 70 ... of the biggest problems for busy executives trying to get in shape ...
... N.Y. -- The role of pharmacists hasn,t received much ... care. But national and regional studies show that when ... treatment costs and improve outcomes. A study on diabetic ... and Pharmaceutical Sciences identified cost savings with improvements in ...
... , Michigan Business and Professional Association ... Dec. 29 Eighty-three percent of the owners of small ... care plan as a public option for insurance, according to ... Business and Professional Association (MBPA) and the Michigan ...
... , , SAN JOSE, Calif. , ... 2009 a year of success in advocacy, research support and ... PF is a fatal disease that has no known cause, ... grassroots fundraising efforts in 2009, further advancing the effort to ...
Cached Medicine News:Health News:Caution Can Help Keep Elderly Safe During Winter 2Health News:Patients Medical Warns Against The Manhattan Diet 2Health News:Pharmacists improve care of diabetics while cutting costs, UB research shows 2Health News:Pharmacists improve care of diabetics while cutting costs, UB research shows 3Health News:83 Percent of Small Businesses Say 'No' to Health Care Public Option, 89 Percent Say Government Cannot Provide Adequate Health Care 2Health News:83 Percent of Small Businesses Say 'No' to Health Care Public Option, 89 Percent Say Government Cannot Provide Adequate Health Care 3Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 2Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 3Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 4
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: